241 related articles for article (PubMed ID: 15722353)
1. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
Tsuji T; Kunieda T
J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
[TBL] [Abstract][Full Text] [Related]
2. Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia.
Sogawa C; Tsuji T; Shinkai Y; Katayama K; Kunieda T
J Hered; 2007; 98(6):575-80. PubMed ID: 17728275
[TBL] [Abstract][Full Text] [Related]
3. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
[TBL] [Abstract][Full Text] [Related]
4. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal tract disorder in natriuretic peptide receptor B gene mutant mice.
Sogawa C; Abe A; Tsuji T; Koizumi M; Saga T; Kunieda T
Am J Pathol; 2010 Aug; 177(2):822-8. PubMed ID: 20616347
[TBL] [Abstract][Full Text] [Related]
6. Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Miura K; Kim OH; Lee HR; Namba N; Michigami T; Yoo WJ; Choi IH; Ozono K; Cho TJ
Am J Med Genet A; 2014 Jan; 164A(1):156-63. PubMed ID: 24259409
[TBL] [Abstract][Full Text] [Related]
7. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice.
Yoder AR; Kruse AC; Earhart CA; Ohlendorf DH; Potter LR
Peptides; 2008 Sep; 29(9):1575-81. PubMed ID: 18554750
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone stimulates expression of C-type Natriuretic Peptide in chondrocytes.
Agoston H; Baybayan L; Beier F
BMC Musculoskelet Disord; 2006 Nov; 7():87. PubMed ID: 17116261
[TBL] [Abstract][Full Text] [Related]
9. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR
Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346
[TBL] [Abstract][Full Text] [Related]
10. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
[TBL] [Abstract][Full Text] [Related]
11. Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B.
Robinson JW; Egbert JR; Davydova J; Schmidt H; Jaffe LA; Potter LR
Cell Signal; 2017 Dec; 40():222-229. PubMed ID: 28964968
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous NPR2 Mutations Cause Disproportionate Short Stature, Similar to Léri-Weill Dyschondrosteosis.
Hisado-Oliva A; Garre-Vázquez AI; Santaolalla-Caballero F; Belinchón A; Barreda-Bonis AC; Vasques GA; Ramirez J; Luzuriaga C; Carlone G; González-Casado I; Benito-Sanz S; Jorge AA; Campos-Barros A; Heath KE
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1133-42. PubMed ID: 26075495
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
14. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
[TBL] [Abstract][Full Text] [Related]
15. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Miura K; Namba N; Fujiwara M; Ohata Y; Ishida H; Kitaoka T; Kubota T; Hirai H; Higuchi C; Tsumaki N; Yoshikawa H; Sakai N; Michigami T; Ozono K
PLoS One; 2012; 7(8):e42180. PubMed ID: 22870295
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
Vasques GA; Amano N; Docko AJ; Funari MF; Quedas EP; Nishi MY; Arnhold IJ; Hasegawa T; Jorge AA
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1636-44. PubMed ID: 24001744
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Bartels CF; Bükülmez H; Padayatti P; Rhee DK; van Ravenswaaij-Arts C; Pauli RM; Mundlos S; Chitayat D; Shih LY; Al-Gazali LI; Kant S; Cole T; Morton J; Cormier-Daire V; Faivre L; Lees M; Kirk J; Mortier GR; Leroy J; Zabel B; Kim CA; Crow Y; Braverman NE; van den Akker F; Warman ML
Am J Hum Genet; 2004 Jul; 75(1):27-34. PubMed ID: 15146390
[TBL] [Abstract][Full Text] [Related]
18. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
Dickey DM; Otto NM; Potter LR
J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
Amano N; Mukai T; Ito Y; Narumi S; Tanaka T; Yokoya S; Ogata T; Hasegawa T
J Clin Endocrinol Metab; 2014 Apr; 99(4):E713-8. PubMed ID: 24471569
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice.
Blaser MC; Wei K; Adams RLE; Zhou YQ; Caruso LL; Mirzaei Z; Lam AY; Tam RKK; Zhang H; Heximer SP; Henkelman RM; Simmons CA
Circ Res; 2018 Feb; 122(3):405-416. PubMed ID: 29273600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
